A Detailed Look at Cannabis Sales in Illinois, Maryland and Massachusetts
We are pleased to share with our readers overviews on three Eastern cannabis markets compiled by BDSA for the month of June. BDSA offers a full understanding of the evolving cannabis market though several offerings, including its GreenEdge Retail Sales Tracking, Consumer Insights, Industry Intelligence and CBD Market Monitor divisions.
BDSA has been sharing data for Massachusetts only since October, so the comparisons to year ago levels aren’t available. Similarly, it began publishing medical data for Illinois, which launched adult-use in January, in July. Maryland, however, has data back to January 2019, which allows for year-over-year comparisons. Each of these relatively new limited-license markets are very different from the more mature Western cannabis markets, which BDSA has profiled at New Cannabis Ventures as well.
Here is a closer look at each market, as detailed by BDSA:
Illinois
In June 2020, Cannabis sales in Illinois’s medical and adult use channels totaled $77.3 million, growing one percent since May. Year-to-date through June, sales have reached $410.2 million.
Flower sales accounted for nearly 34 percent of overall monthly revenue in June with $26.2 million in sales. Pre-rolled Joints, which are tracked as a separate category, accounted for more than five percent of revenues with $4 million in sales. Compared to the trailing month, Flower sales increased by 14 percent and Pre-rolled Joints grew by 52 percent.
The Concentrates category, which was the largest segment of the Illinois cannabis market, accounted for 40 percent of total June revenues with sales reaching $31.1 million for the month. Vape products, the largest segment of the Concentrates category, generated $25.2 million, accounting for 81 percent of the Illinois Concentrates market and 33 percent of sales across all categories.
The Ingestibles category includes both Edibles and Sublinguals while also distinguishing the two subcategories. The Ingestibles category made up 19 percent of overall sales in June with $14.8 million in monthly revenue. In June, the $14.6 million in Edibles sales accounted for nearly 99 percent of Ingestibles sales overall, while Sublinguals made up the remaining one percent. Compared to the trailing month, Edibles sales declined six percent and Sublingual sales declined by about 22 percent.
Maryland
In June 2020, Cannabis sales in Maryland’s medical dispensaries reached $37.9 million, declining by two percent from May. Compared to the previous June, sales in Maryland grew by more than 83 percent. Year-to-date through June, sales reached $201.3 million, representing a $95.1 million increase from the same period last year.
Flower sales accounted for almost 52 percent of overall monthly revenue with $19.5 million in sales. Pre-rolled Joints, which are tracked as a separate category, accounted for seven percent of revenues with $2.6 million in sales. Compared to the previous June, sales of Flower grew by 89 percent and Pre-rolled Joints increased by 103 percent.
Concentrate sales accounted for 28 percent of overall June revenues totaling $10.6 million for the month, representing a one percent decline from May. Vape products, the largest segment of the Concentrates category, generated $7.4 million in sales, making up 70 percent of the Maryland Concentrates market and nearly 20 percent of sales across all categories. Compared to June 2019, sales of Dabbable Concentrates grew by 70 percent, while Vape sales grew by 60 percent.
The Ingestibles category contributed almost 12 percent of sales in June with $4.5 million in revenue. In June, sales from Edibles generated nearly 91 percent of Ingestibles sales overall, decreasing less than one percent from May. Sublinguals sales made up the remaining nine percent and grew by three percent from the trailing month. Compared to the previous June, Edibles sales grew by 168 percent and Sublingual sales increased by 20 percent.
Massachusetts
In June 2020, Cannabis sales in Massachusetts’s adult use and medical channels reached a combined $74.3 million, growing by 116 percent from May. The rapid growth from the trailing month reflects the reality that adult-use dispensaries were only open for a partial month in May. Year-to-date through June, total market sales have exceeded $320.7 million.
Flower sales accounted for 49 percent of overall monthly revenue in June with $36.7 million in sales. Pre-rolled Joints, which are tracked as a separate category, accounted for nearly 11 percent of revenues with $7.8 million in sales. Compared to the trailing month, sales of Flower grew by 120 percent and Pre-rolled Joints increased by 127 percent.
Concentrate sales accounted for more than 23 percent of overall June revenues with sales totaling $17.3 million. Vape products, the largest segment of the Concentrates category, generated $12.5 million in sales. The category made up 73 percent of the Massachusetts Concentrates market and nearly 17 percent of sales across all categories.
The Ingestibles category includes both Edibles and Sublinguals while also distinguishing the two subcategories. The Ingestibles category made up 15 percent of overall sales in June with $11.5 million in monthly revenue. In June, the $9.8 million in Edibles sales generated about 85 percent of Ingestibles sales overall, while Sublinguals made up the remaining 15 percent. Compared to the trailing month, Edibles sales grew by nearly 109 percent and Sublingual sales increased by 97 percent.
For readers looking for a deeper look at cannabis markets across these three states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how the BDSA GreenEdge Platform can provide you with unlimited access to the most accurate and actionable data and analysis.
